Management of Post-Operative Pruritus in Elderly Hip Replacement Patients

First-Line Treatments

For an elderly post-operative hip replacement patient with pruritus, the American College of Physicians recommends starting with gabapentin as the first-line oral agent, while strictly avoiding sedating antihistamines due to fall risk and cognitive impairment 1
In the context of opioid-induced pruritus, diphenhydramine 25-50 mg orally is recommended as initial treatment, despite general cautions about sedating antihistamines in the elderly, with a strength of evidence based on clinical guidelines 2

For opioid-induced pruritus, alternative options include promethazine if diphenhydramine is ineffective, with careful consideration of the patient's overall clinical condition 2
Second-line options for opioid-induced pruritus include naloxone or naltrexone with careful dose titration, nalbuphine, and methylnaltrexone, which may be considered based on the patient's response to initial treatment and individual risk factors 2
Mirtazapine 30 mg daily and gabapentin 1200 mg daily in divided doses have been shown to prevent morphine-induced pruritus in surgical patients, with a moderate strength of evidence based on randomized controlled trials 3

Ondansetron is not recommended for opioid-induced pruritus, as it does not reduce the incidence or time to onset of pruritus compared to placebo, with a high strength of evidence based on multiple studies 2, 3
Sedating antihistamines, such as hydroxyzine and diphenhydramine for non-opioid pruritus, are contraindicated in elderly patients due to fall risk, cognitive impairment, and anticholinergic burden, with a strong strength of recommendation based on clinical guidelines 1

NSAIDs should be used with extreme caution and are contraindicated in those with renal dysfunction, with a moderate strength of evidence based on clinical studies 5
Opioids and tramadol require dose reduction in patients with renal dysfunction, with a moderate strength of evidence based on clinical studies 5
Referral to secondary care is recommended if diagnostic uncertainty exists or primary care management fails to relieve symptoms, with a moderate strength of recommendation based on clinical guidelines 1